ELIZABETH HOLCOMB: Open Payments
NPI 1194111385 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 9 payments from 8 companies in 2025. Trend: 2023 $543 · 2024 $851 · 2025 $188
Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $28 |
| ViiV Healthcare Company | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Alkermes, Inc. | 1 | $19 |
| Braeburn Inc. | 1 | $19 |
| Theratechnologies Inc. | 1 | $14 |
Products named: REXULTI, INVEGA, Qelbree, APRETUDE, MOUNJARO, VIVITROL, BRIXADI, EGRIFTA.
Industry payments across LA — which companies pay providers there.
